You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MF

Showing 51 - 75 of 5,757
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza, Human Trial in Estonia, Philippines (H5N1 antigen combined with MF59 adjuvant)

Completed
  • Influenza, Human
  • H5N1 antigen combined with MF59 adjuvant
  • Tallinn, Harjumaa, Estonia
  • +6 more
Jul 21, 2022

Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

Recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablet
  • Canton, Ohio
    Site 01
Aug 18, 2022

Asthma Trial (SCH 32088 mometasone furoate (MF) metered-dose inhaler, Placebo metered-dose inhaler BID)

Withdrawn
  • Asthma
  • SCH 32088 mometasone furoate (MF) metered-dose inhaler
  • Placebo metered-dose inhaler BID
  • (no location specified)
Feb 7, 2022

HIV Trial in United States (MF59, rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • MF59
  • rgp120/HIV-1 SF-2
  • Birmingham, Alabama
  • +3 more
Oct 27, 2021

Influenza Trial in Oxford (MF59 - ATIV)

Completed
  • Influenza
  • MF59 - ATIV
  • Oxford, United Kingdom
    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropic
Nov 26, 2021

HIV Trial in South Africa (ALVAC-HIV (vCP2438), Bivalent Subtype C gp120/MF59, Placebo)

Completed
  • HIV Infections
  • ALVAC-HIV (vCP2438)
  • +2 more
  • Mthatha, Eastern Cape, South Africa
  • +13 more
May 17, 2022

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,

Terminated
  • Mycosis Fungoides
  • +2 more
  • Naloxone Hydrochloride Lotion, 0.5%
  • Placebo Lotion
  • Little Rock, Arkansas
  • +15 more
Oct 26, 2022

HIV Infection Trial in South Africa (ALVAC-HIV, Bivalent Subtype C gp120/MF59®, ALVAC-HIV (vCP2438) Placebo)

Completed
Has Results
  • HIV Infection
  • ALVAC-HIV
  • +3 more
  • Durban, KwaZulu-Natal, South Africa
  • +4 more
Nov 3, 2021

Cognitive Change Trial in Riverside, Madison (C1 - Standard Perceptual Learning (SPL), C2 - Long Training (LT), C3 - Short

Recruiting
  • Cognitive Change
  • C1 - Standard Perceptual Learning (SPL)
  • +12 more
  • Riverside, California
  • +1 more
May 31, 2023

HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (Env 2-3)

Completed
  • HIV Infections
  • HIV Seronegativity
  • Env 2-3
  • Rochester, New York
  • +2 more
Oct 26, 2021

HIV Trial in Birmingham, Nashville, Seattle (Sub C gp140 Vaccine, MF59C.1 Adjuvant)

Completed
  • HIV Infections
  • Sub C gp140 Vaccine
  • MF59C.1 Adjuvant
  • Birmingham, Alabama
  • +2 more
Oct 13, 2021

Knee Injury, Cartilage Injury Trial in Ålesund, Lørenskog (Arthroscopic microfracture (MF), Arthroscopic debridement (AD))

Recruiting
  • Knee Injury
  • Cartilage Injury
  • Arthroscopic microfracture (MF)
  • Arthroscopic debridement (AD)
  • Ålesund, Møre And Romsdal, Norway
  • +1 more
Jun 29, 2022

Metastatic Breast Cancer Trial in Ankara (radiotherapy)

Recruiting
  • Metastatic Breast Cancer
  • radiotherapy
  • Ankara, Turkey
    Lutfi Dogan
Apr 19, 2022

Problem-solving, Clinical Reasoning, Satisfaction Trial in Kowloon (Structured guideline)

Recruiting
  • Problem-solving
  • +2 more
  • Structured guideline
  • Kowloon, Hong Kong
    Florence MF Wong
Feb 19, 2022

Asthma Trial (Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID, Mometasone Furoate MDI (MF MDI), Formoterol

Completed
Has Results
  • Asthma
  • Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID
  • +3 more
  • (no location specified)
Feb 7, 2022

Asthma Trial (mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID, Mometasone furoate MDI (MF MDI) 200 mcg,

Completed
Has Results
  • Asthma
  • mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID
  • +3 more
  • (no location specified)
Feb 7, 2022

Healthy Trial in Hollywood, Atlanta, Omaha (IVX-121, IVX-241, Placebo)

Recruiting
  • Healthy
  • IVX-121
  • +3 more
  • Hollywood, Florida
  • +2 more
Dec 22, 2022

SARS-CoV2, Covid19 Trial in Herston (MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg, MF59 adjuvanted SARS-CoV-2 Sclamp vaccine

Active, not recruiting
  • SARS-CoV2
  • Covid19
  • MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg
  • +3 more
  • Herston, Queensland, Australia
    Nucleus Network Brisbane (Q-Pharm Pty Ltd)
Aug 23, 2021

Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Farmington Hills, Sterling Heights

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Farmington Hills, Michigan
  • +1 more
Jun 5, 2021

Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial in Chengdu (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

Recruiting
  • Myeloproliferative Neoplasm (MPN)
  • Myelofibrosis，MF
  • flonoltinib 25mg
  • +5 more
  • Chengdu, Sichuan, China
    West China Hospital Sichuan University
Mar 9, 2022

Influenza Trial (Unadjuvanted seasonal influenza vaccine, SWE adjuvant mixed with unadjuvanted seasonal influenza vaccine

Not yet recruiting
  • Influenza
  • Unadjuvanted seasonal influenza vaccine
  • +2 more
  • (no location specified)
Mar 16, 2022

NSCLC, SCLC, CRPC Trial in Tianjin (JAB-8263)

Recruiting
  • NSCLC
  • +7 more
  • Tianjin, Tianjin, China
    Tianjin
Mar 11, 2022

Perennial Allergic Rhinitis Trial (Placebo for MF, Placebo for FP, Mometasone)

Completed
Has Results
  • Perennial Allergic Rhinitis
  • Placebo for MF
  • +3 more
  • (no location specified)
Feb 7, 2022

Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA, Placebo (matched to ELX/TEZ/IVA))

Completed
Has Results
  • Cystic Fibrosis
  • Nedlands, Australia
  • +33 more
Jul 1, 2022

Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)

Not yet recruiting
  • Myeloproliferative Neoplasm (MPN)
  • Myelofibrosis，MF
  • flonoltinib 25mg
  • +5 more
  • (no location specified)
Nov 2, 2021